| scholarly article | Q13442814 |
| P356 | DOI | 10.3168/JDS.S0022-0302(94)77026-0 |
| P698 | PubMed publication ID | 8201050 |
| P2093 | author name string | Yamamoto N | |
| Takano T | |||
| Akino A | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Lactobacillus helveticus | Q142378 |
| P304 | page(s) | 917-922 | |
| P577 | publication date | 1994-04-01 | |
| P1433 | published in | Journal of Dairy Science | Q2293258 |
| P1476 | title | Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. | |
| P478 | volume | 77 |
| Q42378824 | Adjacent-possible ecological niche: growth of Lactobacillus species co-cultured with Escherichia coli in a synthetic minimal medium. |
| Q26851953 | An update on the cardiovascular pleiotropic effects of milk and milk products |
| Q39890970 | Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species |
| Q44205621 | Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine alphaS2-casein |
| Q91631857 | Angiotensin-I-converting enzyme inhibitory peptides in milk fermented by indigenous lactic acid bacteria |
| Q37709455 | Antihypertensive Peptides from Milk Proteins |
| Q41525032 | Antihypertensive peptides derived from food proteins |
| Q38459630 | Antihypertensive peptides of animal origin: A review |
| Q40081529 | Beyond gut feelings: how the gut microbiota regulates blood pressure. |
| Q39293788 | Bioactive Peptides in Animal Food Products |
| Q35593485 | Bioactive peptides and proteins |
| Q37174449 | Bioactive peptides and proteins from foods: indication for health effects |
| Q59302528 | Bioactive peptides generated in an enzyme membrane reactor using Bacillus lentus alkaline peptidase |
| Q38582170 | Bioactive peptides of animal origin: a review |
| Q34177098 | Bioactive substances in milk with properties decreasing risk of cardiovascular diseases |
| Q41525024 | Biochemical properties of regulatory peptides derived from mil proteins |
| Q35913360 | Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors. |
| Q34432216 | Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026. |
| Q58855632 | Detailed peptide profiling of “Scotta”: from a dairy waste to a source of potential health-promoting compounds |
| Q64056397 | Effect of Casein Hydrolysates on Intestinal Cell Migration and Their Peptide Profiles by LC-ESI/MS/MS |
| Q47290318 | Effects of natural peptides from food proteins on angiotensin converting enzyme activity and hypertension |
| Q33667280 | Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease |
| Q35498598 | Enzymatic digestion of the milk protein beta-casein releases potent chemotactic peptide(s) for monocytes and macrophages |
| Q36525881 | Genome sequence and analysis of Lactobacillus helveticus |
| Q36407339 | Health-Promoting Properties of Lactobacillus helveticus. |
| Q37491375 | Health-Related Aspects of Milk Proteins |
| Q36502407 | Identification of Antihypertensive Peptides Derived from Low Molecular Weight Casein Hydrolysates Generated during Fermentation by Bifidobacterium longum KACC 91563 |
| Q33686486 | In situ generation of milk protein-derived peptides in drying-off cows |
| Q91832357 | Influence of Kluyveromyces marxianus on proteins, peptides, and amino acids in Lactobacillus-fermented milk |
| Q47361549 | Kefir Peptides Prevent Hyperlipidemia and Obesity in High-Fat-Diet-Induced Obese Rats via Lipid Metabolism Modulation. |
| Q36655465 | Lactobacillus helveticus: the proteolytic system |
| Q33887959 | Milk and diabetes |
| Q37725759 | Milk protein peptides with angiotensin I-converting enzyme inhibitory (ACEI) activity. |
| Q38827062 | Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis. |
| Q43121724 | Milk-derived bioactive peptides inhibit human endothelial-monocyte interactions via PPAR-γ dependent regulation of NF-κB. |
| Q33887964 | Nutritional and physiological criteria in the assessment of milk protein quality for humans |
| Q51821600 | Optimised production and spray drying of ACE-inhibitory enzyme-modified cheese. |
| Q47749408 | Peptide inhibitors for angiotensin I-converting enzyme from enzymatic hydrolysates of porcine skeletal muscle proteins. |
| Q64259359 | Peptides from Cauliflower By-Products, Obtained by an Efficient, Ecosustainable, and Semi-Industrial Method, Exert Protective Effects on Endothelial Function |
| Q35605674 | Peptides from milk proteins and their properties |
| Q34422470 | Presence of Active and Inactive Molecules of a Cell Wall-Associated Proteinase in Lactobacillus helveticus CP790. |
| Q53813614 | Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension. |
| Q39487400 | Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. |
| Q39485128 | Purification and molecular characterization of a tripeptidase (PepT) from Lactobacillus helveticus |
| Q39700588 | Raised Cecal Veillonella (Firmicutes)/S 24-7 (Bacteriodetes) May Not Cause Salt-Sensitive Hypertension |
| Q36371469 | Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyI-L-proline): II. Introduction |
| Q37903711 | The potential role of milk-derived peptides in cardiovascular disease |
| Q73489033 | Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2 |
| Q84576909 | WITHDRAWN: Bioactive peptides derived from meat proteins |
| Q41887757 | prtH2, not prtH, is the ubiquitous cell wall proteinase gene in Lactobacillus helveticus. |
Search more.